Providence St. Joseph Health

Providence St. Joseph Health Digital Commons
Providence Pharmacy PGY2 Program at
Providence Medical Group 2021

Providence Pharmacy PGY2 Program at
Providence Medical Group

5-2021

Assessing the effect of an electronic health record order entry
guideline on duration of outpatientantimicrobial therapy
prescribed for uncomplicated urinary tract infections
Kasey Rubin
Chelsea Houshour
Christine Doran

Follow this and additional works at: https://digitalcommons.psjhealth.org/oaa_pmg_21
Part of the Pharmacy and Pharmaceutical Sciences Commons

Assessing the effect of an electronic health record order entry guideline on duration
of outpatient antimicrobial therapy prescribed for uncomplicated urinary tract
infections

Health & Services

Kasey Rubin, PharmD; Chelsea Houshour PharmD, BCACP; Christine Doran PharmD, BCACP, MBA

Background

•It has been estimated that resistant infections affect
nearly 3 million Americans annually and are the
cause of 35,000 deaths each year with added costs
up to $33.2 billion dollars1.
•The Centers for Disease Control (CDC) recommends
that outpatient antimicrobial stewardship programs
identify “high priority conditions.”
•Examples of high priority conditions include acute
respiratory infections, urinary tract infections (UTI)
and skin and soft tissue infections (SSTI).2
•Antibiotics are not associated with a diagnosis code
and no specific guidance provided on duration in
EHR
•Providence St. Joseph Health (PSJH) created an
outpatient antimicrobial stewardship guideline to
assist with prescribing practices of antimicrobials in
the outpatient setting. This guideline will be
integrated into the electronic health record (EHR) at
order entry.
•The PSJH guidelines are based on guideline directed
therapy by Infectious Diseases Society of America
(IDSA) and American Academy of Family Physicians
(AAFP) among others.

Methods
•Study design
•Retrospective/Prospective
•Pre-intervention: November 2020 – January 2021
•Post-intervention: To be determined
•Primary Outcome
•Duration of therapy for uncomplicated UTIs
measured in days
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Encounter Type (N=77)

•Exclusion criteria
•Antibiotics prescribed within 30 days at the time of
index date
•Patients who were/are pregnant at the time
antibiotic prescription
•Patients with complicated UTIs, chronic UTIs or
pyelonephritis
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•The sample selected for evaluating secondary
outcomes was not randomized. Instead, patients were
selected if they were prescribed an antibiotic that is
not first-line or for a longer duration than generally
recommended

•Analyze results utilizing ANOVA statistical testing
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•Associate prescribed antibiotics with appropriate and
accurate diagnosis codes
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•The guideline has not been uploaded due to system
delays with pandemic

•An opportunity exists for clinic pharmacists to educate
providers on UTI prescribing practices
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Limitations

•Collect data once EHR guideline is implemented to
determine post-intervention prescribing patterns

Pre-Intervention Average Day Supply for Uncomplicated UTI
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•Based on results from selective sample size, guideline
tool could provide a decrease in duration of therapy
especially for TMP/SMX and FQNs

Next Steps

3

My Chart Message

•Based on a sample size of 100 patients:
•Fifty-two percent of patients had allergies that
affected treatment decisions which may lead to
antibiotic challenge workflow/protocols
•The prevalence of guideline directed antibiotic choice
was 85% based on a sample size of 100 patients
•The duration of therapy was inappropriate 70% of
the time based on a sample size of 100 patients

•A future limitation of this study is providers choosing
to not utilize the guideline resulting in no change in
prescribing patterns
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Virtual Visit

•Antimicrobials were over-prescribed on average by the
following amount of days for uncomplicated UTIs:
•Beta-lactams: 0.8 days
•Nitrofurantoin: 1.4 days
•Trimethoprim/Sulfamethoxazole (TMP/SMX): 2 days
•Fluroquinolones (FQN): 2.3 days

•Selective sample size to identify trends in prescribing
patterns which lead to more TMP/SMX and FQN
prescriptions
•Ex: FQNs prescribed for 7 days
•Ex: TMP/SMX prescribed for 5-7 days
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Office Visit

•Secondary Outcome
•Percentage of appropriate prescriptions based on
guideline directed therapy
•Inclusion criteria
•>18 years old
•Diagnosis code of N.39 within the designated time
frame at PMG primary care clinics and
urgent/immediate care clinics
•All encounter types: office visit, telephone, virtual,
MyChart, orders only

Percentage

•Outside of unnecessary prescribing, the antibiotics
chosen can be incorrect with an inappropriate
duration of therapy1.

Results Continued

Percentage of Patients with Allergies to
Antimicrobials in Secondary
Outcome Sample
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•Fifty percent of antibiotics prescribed in the
outpatient setting are unnecessary1.
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